FUNDED RESEARCH

Giant Cell Myocarditis Treatment Trial
Principal Investigator: L. Cooper, MD
NIH/Governmental Funding

Genetic Modulation of Left Ventricular Recovery
Principal Investigator: D. McNamara, MD
NIH/Governmental Funding

Vascular Medicine Clinical Research Training Program
Principal Investigator: J. Heit, MD; Coordinating Investigator: L.Cooper, MD
NIH/Governmental Funding

Role of TEH Co-stimulator Molecular Slam
Principal Investigator: William A. Faubion, MD
NIH/Governmental Funding

Role of Vitamin D in Dendritic Cell Immune Functions
Principal Investigator: Matthew D. Griffin, MD
NIH/Governmental Funding

Roles of Dendritic Cells in Rena Immune Responses
Principal Investigator: Matthew D. Griffin, MD
NIH/Governmental Funding

Mechanisms of Eosinophil Degranulation in Human Disease
Principal Investigator: Hirohito Kita, MD
NIH/Governmental Funding

Mechanisms of Eosinophilic Inflammation in Human Asthma
Principal Investigator: Hirohito Kita, MD
NIH/Governmental Funding

Modulation of Human Eosinophil Survival
Principal Investigator: Hirohito Kita, MD
Industry Funding

Pathogenesis of Chronic Rhinosinusitis
Principal Investigator: Hirohito Kita, MD
NIH/Governmental Funding

Autoimmunity Targeting Water Channels
Principal Investigator: Vanda Lennon, MD, PhD
Industry Funding

Pathobiology of the Enteric Nervous System: Project #2 Leader: Autoimmune and Diabetic Dysmotility
Principal Investigator: Vanda Lennon, MD, PhD
NIH/Governmental Funding

Spectrum of Autoimmune Gastrointestinal Dysmotility
Principal Investigator: Vanda Lennon, MD, PhD
NIH/Governmental Funding

Genetic Polymorphisms in Rheumatoid Arthritis
Principal Investigator: Eric L. Matteson, MD
NIH/Governmental Funding

Phase 2, Multi-center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Safety, Tolerability and Efficacy of Lymphostat-B Antibody in Subjects with Rheumatoid Arthritis
Principal Investigator: Eric L. Matteson, MD
Industry Funding

Randomized Double-Masked, Placebo-Controlled, Multi-center Study of the Safety and Efficacy of Infliximab in Subjects with Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Anti-TNFS Therapies
Principal Investigator: Eric L. Matteson, MD
Industry Funding

Randomized Double-Masked, Placebo-Controlled, Multi-center Study of the Safety and Efficacy of Infliximab in Subjects with Giant Cell Arteritis
Principal Investigator: Eric L. Matteson, MD
Industry Funding

Support of Educational Activities for Current Fellow in Training
Principal Investigator: Eric L. Matteson, MD
Industry Funding

Support for Training of Rheumatology Fellow
Principal Investigator: Eric L. Matteson, MD
Industry Funding

Celiac Disease Studies
Principal Investigator: Joseph A. Murray, MD
Industry Funding

Epidemiology of Celiac Disease: A Population-based Study
Principal Investigator: Joseph A. Murray, MD
NIH/Governmental Funding

APPLE Study: Prevention of Cardiovascular Complications of Pediatric Systemic Lupus Erythematosus: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
Principal Investigator: Ann M. Reed, MD
NIH/Governmental Funding

Genetic Effect on Breaking Tolerance
Principal Investigator: Ann M. Reed, MD
Foundation Funding

HLA Genetics and Chimerism in Juvenile Dermatomyositis
Principal Investigator: Ann M. Reed, MD
Foundation Funding

Alterations in Dendritic Cell-Mediated Immunity Caused by Smoking
Principal Investigator: Robert Vassallo, MD
Foundation Funding

Role of TSLP in the Pathogenesis of Pulmonary LCH
Principal Investigator: Robert Vassallo, MD
Foundation Funding